Biosyntech (Biosyntech) Net Change in Cash : $-4.06 Mil (TTM As of Dec. 2009)

View and export this data going back to 2000. Start your Free Trial

What is Biosyntech Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Biosyntech's Net Change in Cash for the three months ended in Dec. 2009 was $0.71 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2009 was $-4.06 Mil.

Biosyntech Net Change in Cash Historical Data

The historical data trend for Biosyntech's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosyntech Net Change in Cash Chart

Biosyntech Annual Data

Trend

Mar00

Mar01

Mar02

Mar03

Mar04

Mar05

Mar06

Mar07

Mar08

Mar09

Net Change in Cash

Get a 7-Day Free Trial

-0.76

3.23

-0.51

-1.20

0.76

Biosyntech Quarterly Data
	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09
Net Change in Cash	Get a 7-Day Free Trial															-2.44	-1.97	-1.88	-0.91	0.71

Biosyntech Net Change in Cash Calculation

Biosyntech's Net Change in Cash for the fiscal year that ended in Mar. 2009 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-7.571	+	-0.184	+	8.512	+	0.007
	=	0.76

Biosyntech's Net Change in Cash for the quarter that ended in Dec. 2009

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -1.477 + 0 + 2.177 + 0.009

= 0.71

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2009 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biosyntech Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Biosyntech's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosyntech (Biosyntech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosyntech Inc (OTCPK:BSYI) » Definitions » Net Change in Cash

Comparable Companies

NSPX BOM:531207 BOM:532041 HSTC PZRXQ PRGBQ XCNQ:ZRO BOM:540108 XSAT:EURI B BOM:524604 NTRR ADYNF BOM:506365 VODG SOAN TSXV:WAVE BPSR PTEO LSE:PEBI OSTO:BAYN

Traded in Other Exchanges

N/A

Address

475 Boulevard Armand-Frappier, Laval, QC, CAN, H7V 4B3

Website

http://www.biosyntech.com

Biosyntech Inc is engaged in developing advanced biotherapeutics thermogels specifically designed for tissue repair and delivery of therapeutic agents. The company's products include BST-CarGel, BST-InPod, BST-DermOn, BST-Ossifil and BST-Ossifix and BST-Disc for intervertebral disc restoration.

Biosyntech (Biosyntech) Headlines

No Headlines